Clinical Trials Insight: 700021619
Phase of Trial: Phase I/II
Latest Information Update: 02 Sep 2008
At a glance
- Drugs TM 30339 (Primary)
- Indications Obesity
- Focus Adverse reactions
- Sponsors 7TM Pharma
- 02 Sep 2008 Status changed from not yet recruiting to recruiting.
- 14 Mar 2007 New trial record.